Speakers
CAR-T (Chimeric Antigen Receptor T Cells)
Bryan D. Choi, M.D., Ph.D.Cellular Immunotherapy Program, Cancer Center, Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA |
|
Yu-Hsiang Chang ,M.D., Ph.D. 張裕享 醫師Tai Chen Stem Cell Therapy Center; National Taiwan University Hospital |
|
Shao Chih Chiu, Ph.D. 邱紹智 博士Graduate Institute of Biomedical Sciences, China Medical University , Center for Cell Therapy, China Medical University Hospital |
ADC (Antibody-Drug Conjugates)
Ming-Tain Lai, Ph.D. 賴明添 博士Chief Scientific Officer, OBI Pharma, Inc. |
|
An-Suei Yang, Ph.D. 楊安綏 博士Research Fellow, Genomics Research Center, Academia Sinica |
|
Shih-Hsien Chuang, Ph.D. 莊士賢 博士Director, Medicinal Chemistry Department, Institute of Pharmaceutics, Development Center for Biotechnology |
Immuno-Oncology (IO)
Cheng-I Wang, Ph.D.Head of the Human Monoclonal Antibody Technology Platform, Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) |
|
Yan-Shen Shan, M.D., Ph.D. 沈延盛 院長Distinguished Professor and Surgeon |
|
Keng-Li Lan, M.D., Ph.D. 藍耿立 醫師Associate Professor, Institute of Traditional Medicine, School of Medicine, National Yang-Ming University; Division of Radiation Oncology, Department of Oncology, Taipei Veterans General Hospital |
|
Shuen-Iu Hung, Ph.D. 洪舜郁 博士Professor/Investigator, Cancer Vaccine & Immune Cell Therapy Core Lab, Department of Medical Research, Chang Gung Memorial Hospital |